HomeInsightsEPS

Parmax Pharma Ltd EPS

Parmax Pharma Ltd EPS

stocks purchased

₹ 0.0 Cr

Volume Transacted

(Nov 7, 2024)

stocks purchased

0.4 K

Stocks Traded

(Nov 7, 2024)

Last Updated on: Nov 08, 2024

Image

Parmax Pharma Ltd

NSE: PARMAXPHARMA

EPS

₹ -12.19

Last updated on: Nov 07, 2024

Key Highlights

  • The Earning per Share of Parmax Pharma Ltd is ₹ -12.19 as of 07 Nov 24.
  • The Earning per Share of Parmax Pharma Ltd changed from ₹ -3.52 to ₹ 0.03 over 9 quarters. This represents a CAGR of NaN% .

Historical Earning per Share of Parmax Pharma Ltd

No data available

* All values are in

Company Fundamentals for Parmax Pharma Ltd

Market Cap

17 Cr

EPS

0.0

P/E Ratio (TTM) *

0.0

P/B Ratio (TTM) *

0.0

Day’s High *

47.0

Day’s Low

46.92

DTE *

56.1

ROE *

-5459.0

52 Week High

54.0

52 Week Low

24.18

ROCE *

-83.7

Market Price Over Time

1M

1Y

3Y

5Y

Monitoring Parmax Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
07 Nov 202447
06 Nov 202446.92
05 Nov 202446.7
04 Nov 202447
01 Nov 202447.24
31 Oct 202445.8
30 Oct 202446.05
29 Oct 202445.95
28 Oct 202445.1
25 Oct 202445.35

BlinkX Score for Parmax Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Parmax Pharma Ltd

Market Value

18

Asset Value

6

2.0 X

Value addition

* All values are in Rupees

Competitive Comparison of EPS

Company NameEPSMarket Cap (INR Cr.)
Parmax Pharma Ltd017
Sun Pharmaceuticals Industries Ltd464,29,841
Divis Laboratories Ltd631,58,179
Cipla Ltd571,27,063
Mankind Pharma Ltd521,09,234
Dr Reddys Laboratories Ltd631,07,398

Historical Market Cap of Parmax Pharma Ltd

No data available

* All values are in crore

Historical Revenue of Parmax Pharma Ltd

No data available

* All values are in crore

Historical EBITDA of Parmax Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Parmax Pharma Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Parmax Pharma Ltd News Hub

News

Parmax Pharma to discuss results

Parmax Pharma will hold a meeting of the Board of Directors of the Company on 14 November ...

Read more

07 Nov 202411:45

News

Parmax Pharma to conduct AGM

Parmax Pharma announced that the Annual General Meeting (AGM) of the company will be held ...

Read more

18 Sep 202416:46

News

Parmax Pharma to declare Quarterly Result

Parmax Pharma will hold a meeting of the Board of Directors of the Company on 14 August 20...

Read more

09 Aug 202414:53

News

Parmax Pharma revises board meeting date

Parmax Pharma has revised the meeting of the Board of Directors which was scheduled to be ...

Read more

29 May 202412:10

News

Parmax Pharma schedules board meeting

Parmax Pharma will hold a meeting of the Board of Directors of the Company on 28 May 2024 ...

Read more

24 May 202412:53

News

Parmax Pharma to hold board meeting

Parmax Pharma will hold a meeting of the Board of Directors of the Company on 14 February ...

Read more

09 Feb 202416:10

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Parmax Pharma Ltd

What is the EPS of Parmax Pharma Ltd stock?

The Earnings Per Share (EPS) of Parmax Pharma Ltd is 0.0. An EPS is the amount of net income attributed to each share of a common stock.

How is Parmax Pharma Ltd EPS calculated?

The EPS of Parmax Pharma Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Parmax Pharma Ltd report its EPS?

Parmax Pharma Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Parmax Pharma Ltd EPS?

Factors that influence the EPS of Parmax Pharma Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Parmax Pharma Ltd EPS growth indicate future performance?

Yes, consistent growth in Parmax Pharma Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*